SW954Homo sapiens (Human)Cancer cell line

Also known as: SW 954, SW-954

🤖 AI SummaryBased on 5 publications

Quick Overview

Human cancer cell line with known genetic alterations.

Detailed Summary

SW954 is a human cancer cell line derived from a vulvar carcinoma. It is used in cancer research to study genetic alterations and their implications in tumor development. The cell line has been characterized for specific mutations and deletions that may contribute to its malignant properties. Research on SW954 focuses on understanding the molecular mechanisms underlying cancer progression and identifying potential therapeutic targets.

Research Applications

Genetic alteration studiesCancer progression mechanismsTherapeutic target identification

Key Characteristics

Known mutations in polarity complex genesHomozygous deletions in specific regionsUsed for in vitro studies of cancer biology
Generated on 6/17/2025

Basic Information

Database IDCVCL_1732
SpeciesHomo sapiens (Human)
Tissue SourceVulva[UBERON:UBERON_0000997]

Donor Information

Age86
Age CategoryAdult
SexFemale

Disease Information

DiseaseVulvar squamous cell carcinoma
LineageVulva/Vagina
SubtypeSquamous Cell Carcinoma of the Vulva/Vagina
OncoTree CodeVSC

DepMap Information

Source TypeATCC
Source IDACH-001400_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg158His (c.473G>A)Homozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11
D13S317
9,11
D16S539
11
D18S51
20
D19S433
14,15
D21S11
30,31
D2S1338
20,24
D3S1358
16
D5S818
11,12
D7S820
11,13
D8S1179
10,13
FGA
23
Penta D
12,13
Penta E
9,14
TH01
8,9.3
TPOX
8
vWA
14,15
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

Analysis of established human carcinoma cell lines for lymphoreticular-associated membrane receptors.

Kerbel R.S., Pross H.F., Leibovitz A.

Int. J. Cancer 20:673-679(1977).